文献速递间质性肺疾病

血液转录组学预测肺纤维化进展及自然杀伤细胞的相关性

Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

通路分析显示模式识别受体通路下调和mTOR通路上调,单细胞RNA测序反卷积提示自然杀伤细胞与进展显著相关。

要点

  • 纵向血液基因表达变化模型较横断面模型降低变异、提高统计效能。
  • FVC进展预测器在独立IPF队列中灵敏度78%、特异度86%。
  • 自然杀伤细胞与IPF进展显著相关,支持其新参与机制。

核心结论

  • 系列转录组变化可预测未来FVC下降。
  • 进展者特征涉及的自然杀伤细胞支持其在IPF进展中的新参与。

研究设计与样本

  • 计算个体基线与4个月血液基因表达变化,并与未来FVC状态回归。
  • 在COMET构建FVC进展预测器,并用独立队列验证。
  • 用健康对照外周血单个核细胞单细胞RNA测序数据作参考,反卷积批量RNA测序数据。

主要发现

  • 纵向模型降低稳定组和进展组内基因表达变异,较横断面模型提高统计效能。
  • FVC进展预测器在独立IPF队列中预测未来FVC下降的灵敏度78%、特异度86%。
  • 模式识别受体通路下调,mTOR通路上调。
  • 单细胞RNA测序反卷积识别自然杀伤细胞与进展显著相关。

关键数值与推荐

  • 进展者定义为FVC下降≥10%。
  • 预测器灵敏度78%、特异度86%(独立IPF队列)。

临床怎么用

  • 可考虑用短期纵向血液基因表达变化辅助预测IPF患者未来FVC下降。
  • 自然杀伤细胞相关通路可能成为IPF进展的新干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Disease activity in idiopathic pulmonary fibrosis (IPF) remains highly variable, poorly understood, and difficult to predict. Objectives: To identify a predictor using short-term longitudinal changes in gene expression that forecasts future FVC decline and to characterize involved pathways and cell types. Methods: Seventy-four patients from COMET (Correlating Outcomes with Biochemical Markers to Estimate Time-Progression in IPF) cohort were dichotomized as progressors (≥10% FVC decline) or stable. Blood gene-expression changes within individuals were calculated between baseline and 4 months and regressed with future FVC status, allowing determination of expression variations, sample size, and statistical power. Pathway analyses were conducted to predict downstream effects and identify new targets. An FVC predictor for progression was constructed in COMET and validated using independent cohorts. Peripheral blood mononuclear single-cell RNA-sequencing data from healthy control subjects were used as references to characterize cell type compositions from bulk peripheral blood mononuclear RNA-sequencing data that were associated with FVC decline. Measurements and Main Results: The longitudinal model reduced gene-expression variations within stable and progressor groups, resulting in increased statistical power when compared with a cross-sectional model. The FVC predictor for progression anticipated patients with future FVC decline with 78% sensitivity and 86% specificity across independent IPF cohorts. Pattern recognition receptor pathways and mTOR pathways were downregulated and upregulated, respectively. Cellular deconvolution using single-cell RNA-sequencing data identified natural killer cells as significantly correlated with progression. Conclusions: Serial transcriptomic change predicts future FVC decline. An analysis of cell types involved in the progressor signature supports the novel involvement of natural killer cells in IPF progression.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Huang Y, Oldham JM, Ma SF, et al. Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells. Am J Respir Crit Care Med. 2021. PMID: 33689671. doi:10.1164/rccm.202008-3093OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。